Stopping Abilify (aripiprazole) without a plan can trigger insomnia, nausea, anxiety, and in some cases a return of the symptoms it was managing. These are real discontinuation effects, not signs that you will need the medication forever. Any change to your dose should be planned with your prescriber, not done on your own.
What Is Abilify and Why Is It Prescribed?
Abilify is the brand name for aripiprazole, an atypical antipsychotic that helps balance dopamine and serotonin in the brain [1]. Unlike older antipsychotics that block dopamine directly, aripiprazole regulates and stabilizes the dopamine system. It also affects serotonin receptors, so it is used in mood-related conditions beyond psychosis.
Aripiprazole is prescribed to treat schizophrenia, bipolar disorder, Tourette syndrome, and autism spectrum disorder. It may be added to an antidepressant to treat depression [1]. That last use is where many people encounter it.
If your antidepressant alone was not doing enough, a prescriber may have complemented it with Abilify to boost its effectiveness. It is one of several atypical antipsychotics commonly used this way alongside medications like Seroquel (quetiapine).
Can I Stop Taking Abilify If My Depression Is Better?
This is one of the most common questions people ask, and it deserves a direct answer: possibly yes, but not on your own and not abruptly.
Feeling better is often the goal of treatment. When symptoms have stabilized, it is reasonable to explore whether a dose reduction or discontinuation is appropriate.
That conversation belongs with your prescribing clinician. They will evaluate whether the improvement makes sense, whether the original diagnosis still applies, and how to reduce the dose in a safe way.
What is not safe is stopping suddenly. Abrupt discontinuation of antipsychotic medications is associated with a higher risk of withdrawal effects and relapse compared to gradual tapering [3]. The research on safe tapering points consistently points toward slow, planned reductions, not cold cut-offs.
What Are the Symptoms of Abilify Withdrawal?
Abilify withdrawal is real, and aripiprazole users report it at notably high rates. In a survey of 585 people who had attempted to withdraw from antipsychotic medications, 81.7% of aripiprazole users reported withdrawal effects, a higher rate than users of risperidone (60.7%) or quetiapine (67.6%), and aripiprazole users also rated their withdrawal effects as more severe [2].
The most commonly reported symptoms across antipsychotic discontinuation include:
Insomnia is the most frequently reported withdrawal effect [2]. Sleep disruption can begin within days of reducing or stopping the medication and may persist for weeks.
Nausea and gastrointestinal distress occur as the body adjusts to the absence of the medication’s effects on serotonin and dopamine pathways.
Anxiety and agitation can emerge or intensify during withdrawal, particularly in people who were prescribed Abilify to manage anxiety alongside depression.
Dizziness and sweating are common somatic symptoms in the early days after a dose reduction.
Return of psychiatric symptoms is the most significant concern. Among people who discontinued antipsychotics in the survey, about 18% reported experiencing psychosis during or after withdrawal [2].
It is not always clear whether this represents true withdrawal psychosis or the return of an underlying condition, which is why clinical monitoring during discontinuation matters.
How Long Does Abilify Withdrawal Last?
There is no universal timeline, and Abilify’s pharmacology makes this more complex than some other medications. Abilify has a long half-life, roughly 75 hours. This means it clears the body slowly, which can delay the onset of withdrawal symptoms compared to shorter-acting antipsychotics.
For many people, physical symptoms like nausea and insomnia begin within the first week after stopping and resolve within two to four weeks. Psychological symptoms, including anxiety or mood changes, can take longer to stabilize, particularly if the dose was not tapered gradually.
How Do You Stop Abilify Safely?
Slow, supervised tapering is the safest approach. One research-based approach for tapering on antipsychotics suggests lowering the dose by about a quarter to a half of your current amount, then waiting three to six months before the next cut [3].
That is much slower than most people expect. The brain adjusts to these medications over time, and it needs time to adjust back. Going too fast can bring on withdrawal symptoms or a return of the symptoms the medication was treating.
Here is the safe course of action:
- Working with your prescriber to set a tapering schedule before making any change. Dose reductions should be adjusted based on how you respond to each step down.
- Monitoring for previous symptoms at each reduction. The goal is to find the lowest effective dose or to discontinue entirely, but either outcome requires observation over time, not a single decision.
- Addressing any underlying conditions in parallel. If Abilify was added because depression was not well controlled, the underlying treatment plan should be solid before removing that layer. A dual-diagnosis treatment approach, one that treats the mental health condition alongside any contributing factors is important.
Psychiatric Support at Maple Mountain Mental Health & Wellness
Whether you are considering Abilify withdrawal or questioning your current psychiatric medications, Maple Mountain’s clinical team can help you work through the change.
We offer integrated psychiatric care and medication management alongside treatment for the underlying mental health conditions that often drive medication complexity in the first place.
Are you coming off a medication, reconsidering your treatment plan, or looking for a team that will actually listen? We are here for that conversation.
Sources
[1] Cleveland Clinic. (n.d.). Aripiprazole tablets. Retrieved October 29, 2026, from https://my.clevelandclinic.org/health/drugs/19695-aripiprazole-tablets
[2] Read, J. (2022). The experiences of 585 people when they tried to withdraw from antipsychotic drugs. Addictive Behaviors Reports, 15, 100421. https://doi.org/10.1016/j.abrep.2022.100421
[3] Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021). A method for tapering antipsychotic treatment that may minimize the risk of relapse. Schizophrenia Bulletin, 47(4), 1116–1129. https://doi.org/10.1093/schbul/sbab017